1. Executive Summary

Menopause Practice Growth is a done-for-you growth agency for menopause telehealth clinicians: solo and small-practice MDs, NPs, and PAs who are excellent at the medicine and invisible online. We exist to close that gap using a method we call the Validated Authority Video Method (VAVM): doctor-made video, built from a peer-reviewed, retraction-checked evidence spine, packaged into a website that earns trust, a Google Business Profile that gets her found, and social clips that get her shared.

Our wedge is the evidence layer. Generic marketing agencies sell SEO, ads, and content to every kind of medical practice, dental to medspa to urgent care. None of them check a script against peer-reviewed research before it reaches a clinician, and none of them understand menopause-specific regulatory terrain (NP scope of practice by state, DEA telehealth rules for controlled substances, the fact that testosterone for women is off-label and Schedule III). We do, because Annette built that research capability first, through her own publication (SmartStrongAlive) and a 45,000-comment patient-intelligence analysis plus a 2026 study showing AI tools get menopause medicine dangerously wrong on a regular basis.

We are pre-revenue and building deliberately. We've built the full offer architecture (a three-tier pricing ladder benchmarked against named competitors), a scored prospect pipeline (17 practices enriched so far, 2 hot, 10 warm), a five-email cold-outreach sequence, a lead magnet (the Get-Found Checklist), and a compliance research base (NP scope of practice, controlled-substance rules) that lets our content survive scrutiny in a way competitors' content doesn't. We've also turned the trust-website layer into a real, research-backed product (see Section 3): a proprietary benchmark of 139 live menopause and women's-health sites across five countries, a design playbook drawn from the best of them, and a template gallery a client picks from and we tailor to her practice. We're now running discovery calls to validate that clinicians will actually pay, before we scale outreach or hire anyone.

We're self-funded. That shapes the plan: prove the model with real discovery calls and a low-friction pilot before committing to paid acquisition or headcount, price at parity with named competitors (PatientGain, Healthcare Success, WebFX) so the sale is about differentiation and not a discount fight, and grow client count deal by deal, the same way SponsorLab and Annette's other Claude-built ventures are proving their models before scaling.

2. Problem and Opportunity

The Clinician's Problem

A menopause telehealth provider can be genuinely excellent at the medicine and still run an empty calendar. She doesn't know what to post. She's afraid of saying something medically wrong on the record, so she posts nothing, or posts generically. Cold traffic that lands on her site doesn't trust her yet because there's no proof of competence on the page. Her social accounts, if they exist, don't convert because there's no system behind them. And translating real clinical expertise into content a patient actually wants to watch is a skill she was never trained in and doesn't have time to learn. Underneath all of it sits the business pain that makes her a buyer: she can deliver excellent care and still not fill her schedule, with no repeatable way to fix that.

The Patient's Problem, Which Is the Demand Signal

Our 45,000-comment analysis of real menopause patient conversation found the single loudest unmet need isn't information, it's access: women asking "where do I find a doctor who'll actually prescribe this," alongside a steady stream of dosing confusion. That's a demand signal pointing straight at exactly the clinicians we serve; the market wants these providers found.

The Opportunity

Marketing agencies serving healthcare already exist (PatientGain, Healthcare Success, WebFX), and they're horizontal: dental, medspa, urgent care, and telehealth of every kind, priced $300 to $2,500-plus a month depending on scope. None of them specialize in menopause, none of them run an evidence-validation step, and none of them understand the regulatory terrain their clients operate under (NP scope of practice, controlled-substance telehealth rules). That's the whitespace: a vertical, evidence-backed, compliance-literate version of a service the market already buys at known price points.

3. Solution: What Menopause Practice Growth Does, End to End

1. Prospecting and fit-scoring: We identify independent, cash-pay or membership, menopause-branded telehealth clinicians using a six-dimension fit rubric (provider type, practice control, visible marketing gap, existing effort, decision speed, reachability), scored 0 to 12 and tiered HOT, WARM, COLD. We've run this against 17 practices so far (2 HOT, 10 WARM, 5 COLD, sourced from public sites, Google Business Profiles, and directories, never from private data).
2. Research-led outreach: A five-email sequence (built with clinician-humility and CAN-SPAM rules baked in) leads with a specific, visible gap we found on her own site or profile, never a fabricated stat or an unearned case-study claim, and offers the free Get-Found Checklist as a no-strings first value.
3. Discovery call: We run a short, non-salesy conversation to hear whether patient acquisition is a real, funded, top-of-mind problem for her, using a Situation, Problem, Consequence structure. We track money-behavior signals, not enthusiasm: did she ask about price, did she agree to a pilot.
4. Evidence-checked content production: Every script starts from a validated claims spine: we pull and transcribe what's actually earning views in menopause content, check every claim against peer-reviewed, retraction-checked research, and only then package it into a script the clinician can film in an afternoon, sources attached, hers to use or ignore.
5. Trust-website design, grounded in research, not guesswork: The website is where cold traffic decides whether to trust her, so we don't wing it. We studied the field directly: 139 live menopause and midlife women's-health sites across the US, UK, Canada, Australia, and New Zealand, then scored and ranked the 100 most beautiful on a design rubric and distilled what actually converts into a design playbook: validation-first headlines, an assessment as the primary call to action, embedded video proof, and credentials high on the page. Every client site is built from that playbook and from a gallery of template styles she chooses from, then tailored to her practice, all on the same found, believed, booked structure.
6. The four-layer delivery: Google Business Profile and AI-search optimization get her found. A trust website with embedded videos gets her believed and booked. Instagram and Facebook get her shared, patient to patient. YouTube is the content library feeding all three, picking up long-tail search over time. We never promise to out-rank celebrity menopause educators like Mary Claire Haver or Kelly Casperson in YouTube search; that's not the game and we say so on every sales call.
7. Reporting and renewal: Each tier includes a recurring report (local ranking at the entry tier, a full growth review at the top tier), and we track toward a renewal conversation once a client's pilot or first contract term proves out.

4. Positioning and Differentiation

• Vs. generalist healthcare marketing agencies (PatientGain, Healthcare Success, WebFX): these are real, well-priced competitors, not strawmen. PatientGain publishes GOLD ($799/month), PLATINUM ($1,399/month), and PLATINUM Plus ($1,999+/month) tiers and serves medspas, dental, and telemedicine broadly. Healthcare Success quotes custom retainers for telehealth groups. Neither runs an evidence-validation process on the content it produces, and neither specializes in menopause; a menopause client is one vertical among many they serve the same way.
• Vs. doing nothing (the DIY clinician): the real alternative for most of our prospects today is a thin Squarespace or Wix site, sporadic unplanned social posts, and hidden pricing behind a call. It costs her patients, not dollars, but it's the true baseline we're replacing.
• Vs. generic YouTube growth advice: we are explicit that this is not a promise to make her a YouTube celebrity. A state-licensed telehealth provider will not out-rank a 659,000-subscriber menopause educator in search, and any agency implying she will is selling a fantasy. We sell the real patient journey: found, believed, booked.

Our differentiation:

1. The evidence layer: No script reaches a clinician until its claims survive a peer-reviewed, retraction-checked pass. No competitor in this space runs that step. It's also the reason our content withstands scrutiny that generic health-content agencies' content doesn't.
2. Regulatory fluency: We've done the work on NP scope of practice by state, DEA telehealth flexibilities for controlled substances, and the fact that testosterone for women is off-label and Schedule III. That means our content never overpromises what a clinician can legally do, and we can speak credibly to an NP-run practice's specific constraints, something a generalist agency has no reason to know.
3. Annette's own authority as the front door: SmartStrongAlive is a real publication with a real menopause-and-longevity audience. Our proprietary research (the 45,000-comment analysis, the LLM-menopause study, the ICAHN competitive scan of what's working on menopause YouTube) is content that draws clinician-buyers in, rather than requiring us to cold-outreach our way to every client.
4. Design grounded in a benchmark, not a house style: A generalist agency drops a menopause client into the same layout it uses for a dentist or a medspa. We built a scored benchmark of the 100 most beautiful menopause and women's-health sites across five countries and a playbook of the patterns that convert in this specific niche, so her site is built on what demonstrably works for menopause patients, not a template borrowed from another vertical.

5. Target Market and Beachhead (ICP)

Our beachhead is independent, cash-pay or membership, menopause-branded telehealth clinicians (MD, NP, or PA) in the US, prioritized by our fit rubric. The rubric rewards practices that control their own booking and marketing (so they can say yes without a committee), that show some existing effort (so they already value being found), and that have an obvious, visible gap: no booking link, thin or no website, dead social, hidden pricing.

Real Pipeline Evidence

Of our first 17 enriched prospects, our two HOT leads are Crystal Burke (FNP-C, MSCP) of The Menopause Clinic in New Orleans and Dr. Carolyn Moyers (DO, FACOG, MSCP) of Sky Women's Health in Fort Worth, both menopause-branded, solo-owned, independent cash-pay practices with one clear funnel gap each. The ten WARM leads (including NurtureWell Center, Emerald Health DPC, Radiant Women's Health, and Time for You Winter Park) are solid solo cash-pay clinicians with a single weak dimension: hidden pricing, no online booking, or menopause buried inside a general direct-primary-care offer. We deliberately screened out five COLD prospects, including one practice Annette had publicly (if incorrectly) critiqued, which we're excluding as a prospect on principle.

NPs Are a Fully Valid, Majority ICP, Not an Edge Case

Our own regulatory research confirms roughly 29 states plus DC now grant nurse practitioners full practice authority, meaning an NP can independently diagnose menopause, prescribe HRT and testosterone with her own DEA registration, and own the practice entity outright. Industry pattern (Midi Health, Alloy, and similar platforms) suggests half or more of hands-on menopause telehealth clinicians are NPs, so we don't filter our ICP to MDs only.

Persona Range, Drawn From Annette's Own Sales-Training Program

The solo newly-certified NP three months into her own practice and scared of an empty calendar (budget-cautious but motivated); the established OB-GYN adding a cash-pay menopause line late in his career (has money, guards it, was burned by a prior vendor); the bilingual concierge MD serving US and Spanish-speaking patients (protective of brand quality, wants a partner not a vendor); the overwhelmed small-practice owner with a broken website (wants done-for-you, no more decisions); and the polite, pitched-weekly skeptic who needs a real reason, not enthusiasm. These aren't hypothetical; they're the objection-handling curriculum Annette is drilling against before she runs these calls for real.

6. Market Size (TAM / SAM / SOM)

This sizing is directional. We're not claiming a sourced total market number for "menopause telehealth marketing" because no such market-research category exists yet; instead we size from the comparable market we're actually competing in.

• Total Addressable Market (TAM): the broader US healthcare, medspa, and wellness digital-marketing-services industry that PatientGain, Healthcare Success, and WebFX already serve, priced from roughly $300 to $2,500-plus a month per practice across specialties. This is not our relevant market; it's the horizontal category we're carving a vertical slice out of.
• Serviceable Addressable Market (SAM): independent, cash-pay-leaning, menopause-focused or menopause-branded solo and small-practice clinicians in the US who could plausibly buy a $300 to $2,250-a-month retainer. The Menopause Society's own practitioner directory, our primary sourcing tool, is a specialized, credentialed list, not the entire universe of doctors who happen to treat menopause; directional signal from our own scraping recon put a single unfiltered state query at roughly 20 practitioners per page across an 11-page result set, suggesting a national, credentialed universe in the low thousands once every state and every provider type is pulled. Layer in cash-pay/DPC/concierge menopause practices found outside that directory (the seed list approach we're already running) and we estimate a SAM in the range of 1,500 to 4,000 addressable US practices.

Serviceable Obtainable Market (SOM), Year 1 to 3:

• Assumption: we can realistically service 50 to 75 active retainer clients within three years, given the labor-intensive nature of the flagship video tier.
• Blended value per client: using our own tier mix and pricing, a blended average retainer in the $850 to $1,250 range per active client.
• Math: 25 active clients equals roughly $300,000 in annualized recurring revenue at a $1,000 blended rate; 50 active clients equals roughly $600,000.
• Conclusion: our initial SOM is the revenue from the first 25 to 50 clients we can realistically source, sign, and service inside our chosen niche, a small, credible slice of the multi-hundred-million-dollar broader healthcare-marketing SAM, and one we can reach without needing to compete head-to-head with PatientGain's scale.

7. Revenue Model and Pricing

We run a three-tier monthly retainer ladder, benchmarked directly against named competitor pricing so a prospect can immediately place us on a scale she already understands.

Get Found, $300 a month. Google Business Profile optimization plus two GBP posts a month, local citation cleanup for name/address/phone consistency, review monitoring with suggested (clinician-approved, HIPAA-safe) response drafts, and a monthly one-page local ranking report. No website, video, social, or AI-search work. Delivered mostly through our own automation, which is why it can sit at the floor of the local-SEO market (benchmarked to WebFX's $300 to $2,000/month band).

Get Chosen, $799 a month. Everything in Get Found, plus a menopause-focused landing page we build and maintain, two fact-checked SEO articles a month written from our evidence spine, AI-search (GEO) basics, and a quarterly strategy call. Deliberately no video at this tier; video stays the flagship differentiator. Benchmarked to PatientGain's GOLD tier, priced identically at $799/month.

Get Known, $2,250 a month, the flagship. Everything above, plus weekly fact-checked video scripts. The clinician films 10 to 60 minutes a week (we never quote a fixed number; it depends on takes and camera comfort). We edit and post to her website, Facebook, and Instagram, feed her email list, and run the full AI-search push. Founding Practice rate: $1,250 a month for our first three clients, explicitly traded for a testimonial and case-study rights once we hit the client's growth goal, never offered as a plain discount.

Why we can hold these prices: a menopause telehealth patient is worth hundreds to low thousands of dollars over the relationship (recurring HRT management, labs, follow-ups). One new patient captured through the channel can cover a meaningful share of the monthly fee. That LTV math is what lets us price as a patient-acquisition channel rather than a cheap content subscription, and it's the same math we walk every prospect through on the sales call.

8. Unit Economics

Client-side payback (the number that closes the deal): using the operating-cost anchor a solo telehealth clinician already knows (her EHR runs $300 to $700 a month), and a conservative new-patient value of roughly $300 up front plus ongoing HRT management revenue, a Get Known client breaks even at roughly 7 to 8 new patients a month; a mid-tier client breaks even at roughly 5. That's the pitch line we lead with: for less than she pays for her EHR, she gets a patient pipeline instead of paperwork.

Our-side delivery cost, by tier (illustrative, not yet measured against real delivery hours): Get Found is close to fully automated, so we expect the highest gross margin there, directionally 80 percent-plus once the automation is built out. Get Chosen adds article-writing and a quarterly call, a moderate labor add, directionally 60 to 70 percent gross margin. Get Known is genuinely labor-intensive (script research, evidence-checking, video editing, multi-platform posting), directionally 40 to 50 percent gross margin before any team is hired, which is the honest tradeoff of a service business built around a human clinician's own camera time.

Scale requirement: this is a service and evidence-checking business, not pure software, so revenue scales with headcount and systemization, not for free. 25 active clients at a blended $1,000/month retainer is roughly $25,000 monthly recurring revenue; the evidence-validation pipeline and the video-editing workflow are the two things that most need to be systematized before we can add clients without linearly adding our own hours.

9. Go-to-Market

Phase 1: Prove Buyer Demand Before Scaling Anything

We are sourcing prospects two ways in parallel: a hand-curated, rubric-scored seed list of cash-pay and membership menopause practices (17 enriched so far), and the NAMS/Menopause Society practitioner directory, which we're building a compliant, rate-limited, adversarially-reviewed scraper for (reviewed independently by Gemini, Codex, and Grok before a line of crawler code got written, specifically to avoid a silent, low-completeness failure). Target: 100-plus prioritized prospects, 20 to 30 booked discovery conversations.

Phase 2: the Discovery Call and the Low-Friction Pilot

We're not selling on the first call; we're listening for whether patient acquisition is a real, funded, top-of-mind problem, and watching for money behavior (did she ask about price, would she pay before results land) rather than enthusiasm. Instead of leading with a big retainer, we can offer a small, real-priced pilot (a content-and-scan package) cheap enough to say yes to and real enough to produce a testimonial.

Phase 3: Annette's Own Authority as the Front Door

SmartStrongAlive and our proprietary research (the 45,000-comment analysis, the LLM-menopause study, the YouTube competitive scan) are published as authority content that draws clinician-buyers in on their own, rather than requiring cold outreach for every lead. A clinician who reads "here's what 45,000 future patients are actually asking, and here's where the demand goes unmet" is a warm lead before we've pitched a single service.

Phase 4: Annette's Own Sales Readiness

Because closing high-ticket B2B deals isn't a skill Annette started with, she's running a dedicated sales-training program (role-play against the five buyer personas in Section 5, objection drills, a fear-of-selling ladder) before and alongside real discovery calls, so her close rate on real calls improves deliberately rather than by accident.

10. Defensibility and Moat

1. The evidence-validation pipeline: Every script is checked against peer-reviewed, retraction-checked research before it reaches a clinician. Building that pipeline required Annette's own medical-technology background, an existing publication (SmartStrongAlive), and a working research-and-citation system (the central ResearchLibrary and Zotero setup). A generalist marketing agency would have to build all of that from scratch to compete on the same claim.
2. Regulatory fluency as content-quality control: Our own research into NP scope of practice, DEA telehealth flexibilities, and controlled-substance rules for testosterone means our content never makes a claim a client can't legally back up (never "available everywhere," always "available in states where she's licensed"). That's a genuine, hard-to-copy quality bar in a category where compliance mistakes are expensive.
3. A compounding, scored prospect database: Our fit rubric and enrichment pipeline (public-source research routed through Tavily and DeepSeek, orchestrated by us) builds a growing, scored map of the entire addressable market, HOT, WARM, and COLD, the same way SponsorLab's data moat compounds with every scrape. Ours compounds on the buyer side instead of the payment-link side.
4. Annette's own public authority: A named, credible person publishing primary research is a harder thing for a faceless agency to replicate than an ad budget.
5. A proprietary design-and-conversion benchmark: Our library of 139 scored menopause and women's-health sites, the ranked top 100, the design playbook drawn from them, and the template gallery built on top, is a research asset a generalist agency has no reason to build. It lets us show a prospect exactly where her current site sits against the best in her field, then hand her a design already grounded in what wins.

11. Competitive Landscape

Our wedge: we're the only option combining vertical menopause depth, an evidence-validation moat, and a price ladder a prospect can immediately compare against agencies she's already been pitched by.

12. Risks and Assumptions

• Cold-start risk: we have no signed clients yet. Assumption that discovery calls convert to paid pilots at a reasonable rate. Mitigation: prioritize HOT-tier prospects with an obvious gap, lead with the free Get-Found Checklist, and track money-behavior signals (price questions, upfront cash) rather than politeness on every call.
• Regulatory cliff risk: the DEA's telemedicine flexibility for prescribing controlled substances (including testosterone) without an in-person exam is only extended through December 31, 2026. If it lapses, some of our clients' own telehealth-testosterone workflows could face real friction, which could dent their growth and their willingness to invest in marketing. Mitigation: never anchor client content or pitches on that flexibility alone; diversify content pillars beyond testosterone access; watch the DEA calendar and update client-facing claims immediately if the rule changes.
• Directory compliance risk. The NAMS/Menopause Society directory's terms restrict "unauthorized use, including promotional efforts," and our own scraper plan flags this as a real, unresolved risk rather than a solved one. Mitigation: value-led, opt-out-compliant outreach only, no bulk blasting, rate-limited and content-verified scraping with a hard recon gate before any crawl runs, and a hand-curated seed list as the lower-risk fallback.
• Founder key-person risk. Annette is currently the entire prospecting, sales, evidence-checking, and production team. Mitigation: document the VAVM playbook step by step from the first paid engagement, and hire an editor or researcher only once retainer revenue supports it.
• Service scalability. The flagship Get Known tier requires the clinician's own camera time and our own editing hours; it doesn't scale by adding software. Mitigation: keep the flagship tier explicitly capacity-limited, and systematize the lower, higher-margin tiers first.
• Competitor response. PatientGain or Healthcare Success could bolt on a menopause-specific package or a lighter evidence-checking claim. Mitigation: our moat is the depth of the evidence pipeline and Annette's own public authority, both genuinely costly and slow for a generalist agency to replicate.
• Compliance risk in our own content. Any claim we help a client make must survive scrutiny. Mitigation: every claim is peer-reviewed and retraction-checked before it reaches a clinician, and copy never implies the agency directs a doctor's clinical or prescribing decisions; she is always the medical authority.

13. Roadmap and Milestones

Phase 1: Demand Validation (Now to Month 3)

• Consolidate and expand the prospect pipeline past 100 prioritized practices.
• Run 20 to 30 discovery calls; track close rate and cash-upfront rate against Shane's own coaching-program thresholds (above 20 percent close, cash upfront on more than 30 percent of closes).
• Sign our first 1 to 3 clients through the low-friction pilot or a Founding Practice Get Known contract.

Phase 2: Systemize the Playbook (Months 4 to 9)

• Document the exact prospecting-to-signed-client playbook from the first real engagements.
• Publish the marketing site publicly (currently password-gated and internal-only) once the first case study exists.
• Reach 8 to 12 active retainer clients across all three tiers.

Phase 3: Repeatable Growth (Months 10 to 18)

• Scale to 25-plus active clients.
• Bring on a contract video editor or evidence-research assistant as retainer revenue supports it.
• Pilot the Spanish-language expansion, still English-only client-facing until validated.

Phase 4: Category Expansion (Months 19 to 36)

• Scale to 50-plus active clients.
• Explore adjacent verticals using the same evidence-validation playbook (broader midlife women's health, for example), only once the menopause niche is proven and systemized.

14. Financial Projections (Illustrative, Directional)

Projections are assumptions built from our own tier pricing and unit economics, not forecasts. We have zero signed clients as of this writing; every number below describes a possible trajectory given successful execution of the roadmap above, not a committed plan.

Assumptions: Year 1 includes several months with zero revenue while we run discovery calls and the first pilot; the first signed clients likely land mid-year. Tier mix shifts toward Get Known as case studies accumulate and Founding Practice clients prove the model. Blended retainer rises as Founding Practice discounts roll off after each client's case-study window closes.

Immediate Next Steps

1. Finish and pass the NAMS scraper's hard recon gate, or fall back to expanding the hand-curated seed list past 100 prospects.
2. Run the first 20 to 30 discovery calls, tracking close rate and cash-upfront rate against our own stated thresholds.
3. Close the first paid pilot or Founding Practice contract, and document the exact path from first contact to signature.
4. Complete Annette's sales-training certification against the five buyer personas before running calls with HOT-tier prospects.
5. Publish the marketing site publicly and gate it to production once the first client case study exists.